{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:56:37Z","timestamp":1787028997422,"version":"build-2736575974"},"reference-count":111,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The COVID-19 pandemic has highlighted intricate associations between SARS-CoV-2 infection and autoimmune skin diseases (ASDs). This review examines the bidirectional relationship between COVID-19 and ASDs including hidradenitis suppurativa, psoriasis, atopic dermatitis, alopecia areata, autoimmune bullous diseases, cutaneous and systemic lupus erythematosus, systemic sclerosis, dermatomyositis, and lichen planus. Current evidence indicates that SARS-CoV-2 may precipitate or worsen ASDs via mechanisms such as molecular mimicry, dysregulated cytokine signaling, and enhanced Th1\/Th17 immune responses, leading to loss of self-tolerance and autoantibody production. Epidemiological studies have identified increased incidence and flares of psoriasis, hidradenitis suppurativa, and other ASDs following both COVID-19 infection and vaccination, with mRNA vaccines associated with a higher risk of flare in hidradenitis suppurativa compared with non-mRNA vaccines. Notably, severe COVID-19 is associated with a greater risk of new-onset autoimmune disease, and patients with pre-existing inflammatory skin conditions may have increased susceptibility to SARS-CoV-2 infection but experience less severe COVID-19 courses. These findings underscore the need for ongoing surveillance and mechanistic studies to clarify the immunopathogenic links between SARS-CoV-2 and ASDs and inform management strategies for affected patients in the context of both infection and vaccination.<\/jats:p>","DOI":"10.3390\/microorganisms13092129","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:23:50Z","timestamp":1757600630000},"page":"2129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-8374","authenticated-orcid":false,"given":"Aikaterini I.","family":"Liakou","sequence":"first","affiliation":[{"name":"1st Department of Dermatology and Venereology, \u201cAndreas Syggros\u201d Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-8520","authenticated-orcid":false,"given":"Eleni","family":"Routsi","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology and Venereology, \u201cAndreas Syggros\u201d Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Plisioti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDunarea de Jos\u201d University of Galati, 800008 Galati, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2644-9489","authenticated-orcid":false,"given":"Eleni","family":"Tziona","sequence":"additional","affiliation":[{"name":"Aristotle University School of Medicine, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7074-2374","authenticated-orcid":false,"given":"Dimitra","family":"Koumaki","sequence":"additional","affiliation":[{"name":"Dermatology Department, University Hospital of Heraklion, 71110 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Kalamata","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology and Venereology, \u201cAndreas Syggros\u201d Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia-Konstantina","family":"Bompou","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology and Venereology, \u201cAndreas Syggros\u201d Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-8901","authenticated-orcid":false,"given":"Rozeta","family":"Sokou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaio Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-5674","authenticated-orcid":false,"given":"Petros","family":"Ioannou","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-6579","authenticated-orcid":false,"given":"Stefanos","family":"Bonovas","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emuanuele, 20072 Milan, Italy"},{"name":"IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Samonis","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"},{"name":"1st Oncology Department Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-0759","authenticated-orcid":false,"given":"Andreas G.","family":"Tsantes","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology and Blood Bank Unit, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University, 12462 Athens, Greece"},{"name":"Microbiology Department, \u201cSaint Savvas\u201d Oncology Hospital, 11522 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Stratigos","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology and Venereology, \u201cAndreas Syggros\u201d Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, 16121 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_3","unstructured":"Ballard, K., and Shuman, V.L. (2024). Hidradenitis Suppurativa, StatPearls."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat","year":"2025","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction","volume":"139","author":"Wolk","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liakou, A.I., Tsantes, A.G., Bompou, E.-K., Kalamata, M., Agiasofitou, E., Vladeni, S., Dragoutsou, A., Tsante, K.A., Ioannou, P., and Chatzidimitriou, E. (2025). Risk Factors for Flares and New Lesions of Hidradenitis Suppurativa Following COVID-19 Disease: A Retrospective Cohort Study of 310 Patients in Greece. Microorganisms, 13.","DOI":"10.3390\/microorganisms13030542"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gracia-Ramos, A.E., Martin-Nares, E., and Hern\u00e1ndez-Molina, G. (2021). New onset of autoimmune diseases following COVID-19 diagnosis. Cells, 10.","DOI":"10.3390\/cells10123592"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Cyprian, F.S., Nasrallah, G.K., Al Thani, A.A., Almishal, R.O., and Yassine, H.M. (2019). Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses, 11.","DOI":"10.3390\/v11080762"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Scholl, L., Abu Rached, N., Stockfleth, E., Cramer, P., Ocker, L., Stranzenbach, R., Garcovich, S., Hessam, S., and Bechara, F.G. (2024). Hidradenitis suppurativa in the SARS-CoV-2 pandemic: Investigation of trigger factors in a single center. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144074"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jid.2022.05.277","article-title":"270 Impact of COVID-19 infection on hidradenitis suppurativa activity","volume":"142","author":"Torpey","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.det.2021.05.010","article-title":"The Use of biologics during the COVID-19","volume":"39","author":"Jones","year":"2021","journal-title":"Pandemic Dermatol. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000529462","article-title":"COVID-19 infection in hidradenitis suppurativa patients: A retrospective study","volume":"9","author":"De","year":"2023","journal-title":"Ski. Appendage Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000508528","article-title":"Thyroid disease and active smoking may be associated with more severe hidradenitis suppurativa: Data from a prospective cross sectional single-center study","volume":"237","author":"Liakou","year":"2021","journal-title":"Dermatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa?\u201415 years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdcr.2022.03.008","article-title":"Hidradenitis suppurativa flares following COVID-19 vaccination: A case series","volume":"23","author":"Martora","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdcr.2022.05.005","article-title":"Response to Martora et al\u2019s \u201cHidradenitis suppurativa flares following COVID-19 vaccination: A case series\u201d","volume":"25","author":"Alexander","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ced.15090","article-title":"Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa","volume":"47","author":"Pakhchanian","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bjd\/ljad345","article-title":"Hidradenitis suppurativa: New insights into disease mechanisms and an evolving treatment landscape","volume":"190","author":"Krueger","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2022192","DOI":"10.5826\/dpc.1204a192","article-title":"Impact of COVID-19 pandemic on hidradenitis suppurativa patients: A cross-sectional study from tertiary referral hospital","volume":"12","author":"Bostan","year":"2022","journal-title":"Dermatol. Pr. Concept."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2021.09.016","article-title":"Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry","volume":"86","author":"Naik","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Man, A.-M., Or\u0103san, M.S., Hoteiuc, O.-A., Ol\u0103nescu-Vaida-Voevod, M.-C., and Mocan, T. (2023). Inflammation and psoriasis: A comprehensive review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216095"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zou, Y., Xu, J., Chen, A.-J., Huang, K., Zhu, S.-M., Li, J.-J., He, J., Li, J.-Z., Xiong, J.-X., and Fan, Y.-K. (2024). Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: A cross-sectional survey. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-54424-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_31","first-page":"e14684","article-title":"Psoriasis flare after influenza vaccination in COVID-19 era: A report of four cases from a single center","volume":"34","author":"Armesto","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis pathogenesis and treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zeng, H., Wang, S., Chen, L., and Shen, Z. (2021). Biologics for psoriasis during the COVID-19 pandemic. Front. Med., 8.","DOI":"10.3389\/fmed.2021.759568"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Campanati, A., Diotallevi, F., Martina, E., Radi, G., and Offidani, A. (2022). Treatment of moderate to severe psoriasis during the COVID-19 pandemic: Lessons learned and opportunities. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092422"},{"key":"ref_35","first-page":"e25987","article-title":"Psoriasis flares in patients with COVID-19 infection or vaccination: A case series","volume":"14","author":"Shah","year":"2022","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1111\/jocd.14508","article-title":"Pustular psoriasis flare-up in a patient with COVID-19","volume":"20","author":"Miladi","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_37","first-page":"9722","article-title":"A severe psoriasis flare after COVID-19 treated with risankizumab: Complete skin clearance after 16 weeks","volume":"16","author":"Ibba","year":"2023","journal-title":"Dermatol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1111\/jocd.14396","article-title":"Guttate flare in a patient with chronic plaque psoriasis following COVID-19 infection: A case report","volume":"20","author":"Agarwal","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.12788\/cutis.0443","article-title":"Guttate psoriasis following COVID-19 infection","volume":"109","author":"Janodia","year":"2022","journal-title":"Cutis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2020-4-10","article-title":"Psoriasis, biologic therapy, and the pandemic of the 21st century","volume":"9","author":"Nogueira","year":"2020","journal-title":"Drugs Context"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdin.2021.07.007","article-title":"Teledermatology in the COVID-19 pandemic: A systematic review","volume":"5","author":"Loh","year":"2021","journal-title":"JAAD Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e13805","DOI":"10.1111\/dth.13805","article-title":"COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy","volume":"33","author":"Filippi","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s11136-023-03448-4","article-title":"The differentiating effect of COVID-19-associated stress on the morbidity of blood donors with symptoms of hidradenitis suppurativa, hyperhidrosis, or psoriasis","volume":"32","author":"Henning","year":"2023","journal-title":"Qual. Life Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Messas, T., Lim, R.K., Burns, L., Yumeen, S., and Kroumpouzos, G. (2023). A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory\/biologic therapy: Recommendations should not differ between non-pregnant and pregnant individuals. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1121025"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liakou, A.I., Tsantes, A.G., Routsi, E., Agiasofitou, E., Kalamata, M., Bompou, E.-K., Tsante, K.A., Vladeni, S., Chatzidimitriou, E., and Kotsafti, O. (2024). Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164617"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Freeman, T.L., and Swartz, T.H. (2020). targeting the NLRP3 inflammasome in severe COVID-19. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01518"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Haddad, I., Kozman, K., and Kibbi, A.-G. (2022). Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.809646"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2001-010872","article-title":"Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis","volume":"87","author":"Geiben","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of TH2\/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","first-page":"pe173","article-title":"COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: Real-world observational data","volume":"35","author":"Wijs","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Miodo\u0144ska, M., Bogacz, A., Mr\u00f3z, M., Mu\u0107ka, S., and Bo\u017cek, A. (2021). The effect of SARS-CoV-2 virus infection on the course of atopic dermatitis in patients. Medicina, 57.","DOI":"10.3390\/medicina57060521"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaip.2021.10.050","article-title":"COVID-19 symptoms are attenuated in moderate-to-severe atopic dermatitis patients treated with dupilumab","volume":"10","author":"Ungar","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/all.15827","article-title":"Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease","volume":"79","author":"Schmitt","year":"2023","journal-title":"Allergy"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ad.2021.08.013","article-title":"Impact of COVID-19 pandemic on patients with atopic dermatitis","volume":"113","author":"Pourani","year":"2022","journal-title":"Actas Dermo-Sifiliograficas"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Xie, Y., Lv, S., Luo, S., Chen, Y., Du, M., Xu, Y., and Yang, D. (2024). The correlation between corona virus disease 2019 and alopecia areata: A literature review. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1347311"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40257-017-0312-y","article-title":"Evaluation of the relationship between alopecia areata and viral antigen exposure","volume":"19","author":"Richardson","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/039463201202500327","article-title":"Serum concentrations and IL-2, IL-6, IL-12 and TNF-\u03b1 in patients with alopecia areata","volume":"25","author":"Rossi","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e2336120","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"6","author":"Lim","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13555-021-00498-9","article-title":"Italian survey for the evaluation of the effects of coronavirus disease 2019 (COVID-19) pandemic on alopecia areata recurrence","volume":"11","author":"Rinaldi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamadermatol.2023.5559","article-title":"Risk of alopecia areata after COVID-19","volume":"160","author":"Kim","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic\u2013pituitary\u2013adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_64","first-page":"19","article-title":"COVID 19 and bullous pemphigoid: A hypothesis for a causal link","volume":"36","author":"Lucchese","year":"2022","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2050313X241231423","DOI":"10.1177\/2050313X241231423","article-title":"New-onset of pemphigus following COVID-19 infection: A case report","volume":"12","author":"Pastukhova","year":"2024","journal-title":"SAGE Open Med. Case Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e14398","DOI":"10.1111\/dth.14398","article-title":"Aggressive course of pemphigus vulgaris followingCOVID-19 infection","volume":"33","author":"Ghalamkarpour","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2024.10.063","article-title":"COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individuals","volume":"92","author":"Curman","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaad.2021.02.087","article-title":"The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study","volume":"85","author":"Kridin","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e14265","DOI":"10.1111\/dth.14265","article-title":"Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice","volume":"33","author":"Elmas","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","article-title":"Environmental exposures and the development of systemic lupus erythematosus","volume":"28","author":"Barbhaiya","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s10067-020-05359-y","article-title":"High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: A case-based review: High levels of anti-SSA\/Ro antibodies in COVID-19","volume":"39","author":"Fujii","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"815743","DOI":"10.3389\/fmed.2022.815743","article-title":"Case Report: Rowell Syndrome\u2013Like Flare of Cutaneous Lupus Erythematosus Following COVID-19","volume":"9","author":"Drenovska","year":"2022","journal-title":"Infection. Front. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/omcr\/omad129","article-title":"Lupus panniculitis as the initial presentation of systemic lupus erythematosus triggered by COVID-19 infection: Case report and literature review","volume":"2023","author":"Abuhammad","year":"2023","journal-title":"Oxf. Med. Case Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/annrheumdis-2020-217407","article-title":"Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management","volume":"79","author":"Bruni","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.11604\/pamj.supp.2020.35.2.24549","article-title":"COVID-19 infection during autoimmune disease: Study of 2 cases in Republic of Guinea","volume":"35","author":"Atakla","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/rheumatology\/keaa855","article-title":"Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic","volume":"60","author":"Peach","year":"2020","journal-title":"Rheumatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e253735","DOI":"10.1136\/bcr-2022-253735","article-title":"Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis","volume":"16","author":"Carroll","year":"2023","journal-title":"BMJ Case Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s10067-020-05193-2","article-title":"The systemic sclerosis patient in the COVID-19 era: The challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress","volume":"39","author":"Orlandi","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Shimizu, H., Matsumoto, H., Sasajima, T., Suzuki, T., Okubo, Y., Fujita, Y., Temmoku, J., Yoshida, S., Asano, T., and Ohira, H. (2022). New-onset dermatomyositis following COVID-19: A case report. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1002329"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.2147\/JIR.S369477","article-title":"Dermatomyositis flare after a COVID-19 infection successfully treated with rituximab: A case report and literature review","volume":"15","author":"Albakri","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5662\/wjm.v12.i4.200","article-title":"COVID-19 disease and autoimmune disorders: A mutual pathway","volume":"12","author":"Saeed","year":"2022","journal-title":"World J. Methodol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e30634","DOI":"10.1097\/MD.0000000000030634","article-title":"Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports","volume":"101","author":"Cao","year":"2022","journal-title":"Medicine"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"742826","DOI":"10.1155\/2014\/742826","article-title":"Cutaneous and mucosal lichen planus: A comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis","volume":"2014","author":"Gorouhi","year":"2014","journal-title":"Sci. World J."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Ujiie, H., Rosmarin, D., Sch\u00f6n, M.P., St\u00e4nder, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., and Cole, C. (2022). Unmet medical needs in chronic, non-communicable inflammatory skin diseases. Front. Med., 9.","DOI":"10.3389\/fmed.2022.875492"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/1040841X.2019.1614904","article-title":"The role of viral infections in the development of autoimmune diseases","volume":"45","author":"Hussein","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1523-1747.ep12523539","article-title":"Lichenoid tissue reaction induced by local transfer of ia-reactive t-cell clones","volume":"87","author":"Shiohara","year":"1986","journal-title":"J. Investig. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2133.2000.03355.x","article-title":"Autocytotoxic T-cell clones in lichen planus","volume":"142","author":"Sugerman","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Shiohara, T., Moriya, N., and Nagashima, M. (1992). Induction and Control of Lichenoid Tissue Reactions. Springer Seminars in Immunopathology, Springer.","DOI":"10.1007\/BF00200535"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2133.1998.02045.x","article-title":"Cutaneous reactions at sites of herpes zoster scars: An expanded spectrum","volume":"138","author":"Requena","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000339771","article-title":"Detection of varicella-zoster virus antigens in lesional skin of zosteriform lichen planus but not in that of linear lichen planus","volume":"225","author":"Mizukawa","year":"2012","journal-title":"Dermatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ijd.15338","article-title":"Annular lichen planus associated with coronavirus SARSCoV-2 disease (COVID-19)","volume":"60","author":"Ballester","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jdcr.2022.01.014","article-title":"Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine","volume":"21","author":"Paolino","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e15389","DOI":"10.1111\/dth.15389","article-title":"Lichen Ruber planus occurring after SARS-CoV-2 vaccination","volume":"35","author":"Zengarini","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"102905","DOI":"10.1016\/j.amjoto.2021.102905","article-title":"Oral lesions in COVID 19 positive patients","volume":"42","author":"Fidan","year":"2021","journal-title":"Am. J. Otolaryngol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"103051","DOI":"10.1016\/j.amsu.2021.103051","article-title":"Oral lichen planus after COVID-19, a case report","volume":"72","author":"Saleh","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/ijd.15529","article-title":"COVID-19: A possible trigger for oral lichen planus?","volume":"60","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_98","first-page":"468","article-title":"Lichen Planus after SARS-CoV-2 infection treated with Lopinavir\/Ritonavir","volume":"156","year":"2021","journal-title":"Med. Cl\u00edn."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"110681","DOI":"10.1016\/j.mehy.2021.110681","article-title":"Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection","volume":"156","author":"Sood","year":"2021","journal-title":"Med. Hypotheses"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jdv.17854","article-title":"Skin adverse reactions to SARS-CoV-2 vaccination: A relevant responsibility issue for dermatologists","volume":"36","author":"Gisondi","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_101","first-page":"206","article-title":"High Expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-19","volume":"141","author":"Xue","year":"2021","journal-title":"J. Investig."},{"key":"ref_102","first-page":"615","article-title":"Role of vitamin d and vitamin d receptor in oral lichen planus: A systematic review","volume":"30","author":"Motahari","year":"2020","journal-title":"Ethiop. J. Heal. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4103\/jfmpc.jfmpc_749_19","article-title":"Oral lichen planus and associated comorbidities: An approach to holistic health","volume":"8","author":"Saeed","year":"2019","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Niebel, D., Novak, N., Wilhelmi, J., Ziob, J., Wilsmann-Theis, D., Bieber, T., Wenzel, J., and Braegelmann, C. (2021). Cutaneous adverse reactions to COVID-19 vaccines: Insights from an immuno-dermatological perspective. Vaccines, 9.","DOI":"10.3390\/vaccines9090944"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: Modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Singh, S., Kumar, R., and Agrawal, B. (2019). Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects. Adenoviruses, IntechOpen.","DOI":"10.5772\/intechopen.79697"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0019-5154.94272","article-title":"The role of cytokines in the pathomechanism of cutaneous disorders","volume":"57","author":"Coondoo","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Sprow, G., Afarideh, M., Dan, J., Feng, R., Keyes, E., Grinnell, M., Concha, J., and Werth, V.P. (2022). Autoimmune skin disease exacerbations following COVID-19 vaccination. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.899526"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1111\/jdv.19968","article-title":"Flares and new related lesions of Hidradenitis Suppurativa following COVID-19 vaccination: A retrospective cohort study of 250 patients in Greece","volume":"38","author":"Liakou","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"J\u0119\u015bkowiak-Kossakowska, I., Nowotarska, P., Grosman-Dziewiszek, P., Szel\u0105g, A., and Wiatrak, B. (2024). Impact of comorbidities and skin diseases on post-vaccination reactions: A study on COVID-19 vaccinations in poland. J. Clin. Med., 13.","DOI":"10.3390\/jcm13206173"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat. Rev. Immunol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/9\/2129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:43:56Z","timestamp":1760035436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/9\/2129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":111,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["microorganisms13092129"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13092129","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}